15-26794935-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000541819.6(GABRB3):​c.248+21432A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.43 in 152,060 control chromosomes in the GnomAD database, including 16,729 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 16729 hom., cov: 32)

Consequence

GABRB3
ENST00000541819.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.66

Publications

11 publications found
Variant links:
Genes affected
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000541819.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.602 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000541819.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
ENST00000541819.6
TSL:1
c.248+21432A>C
intron
N/AENSP00000442408.2F5H7N0

Frequencies

GnomAD3 genomes
AF:
0.430
AC:
65303
AN:
151942
Hom.:
16720
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.134
Gnomad AMI
AF:
0.391
Gnomad AMR
AF:
0.611
Gnomad ASJ
AF:
0.571
Gnomad EAS
AF:
0.587
Gnomad SAS
AF:
0.621
Gnomad FIN
AF:
0.507
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.524
Gnomad OTH
AF:
0.476
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.430
AC:
65315
AN:
152060
Hom.:
16729
Cov.:
32
AF XY:
0.439
AC XY:
32601
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.133
AC:
5542
AN:
41526
American (AMR)
AF:
0.612
AC:
9355
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.571
AC:
1978
AN:
3466
East Asian (EAS)
AF:
0.587
AC:
3027
AN:
5156
South Asian (SAS)
AF:
0.620
AC:
2992
AN:
4826
European-Finnish (FIN)
AF:
0.507
AC:
5347
AN:
10550
Middle Eastern (MID)
AF:
0.441
AC:
128
AN:
290
European-Non Finnish (NFE)
AF:
0.524
AC:
35578
AN:
67950
Other (OTH)
AF:
0.480
AC:
1011
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1645
3290
4934
6579
8224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.500
Hom.:
10161
Bravo
AF:
0.423
Asia WGS
AF:
0.621
AC:
2158
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.24
DANN
Benign
0.58
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4906908;
hg19: chr15-27040082;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.